Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$6.53
0.142.19%
Last update: Apr 20, 9:30 AM
Plus Therapeutics Inc (PSTV) Stock Price, Quote, News & History
PSTVNASDAQ
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Plus Therapeutics (PSTV) stock?
You can purchase shares of Plus Therapeutics (NASDAQ:PSTV) through any online brokerage.
Who are Plus Therapeutics (PSTV) competitors?
Other companies in Plus Therapeutics’s space includes: Kezar Life Sciences Inc (NASDAQ:KZR), Evaxion AS (NASDAQ:EVAX), Atossa Therapeutics Inc (NASDAQ:ATOS), Aligos Therapeutics Inc (NASDAQ:ALGS) and Sensei Biotherapeutics Inc (NASDAQ:SNSE).
What is the forecast, or price target, for Plus Therapeutics (PSTV) stock?
Plus Therapeutics has a consensus price target of $23.00.
What is the current price for Plus Therapeutics (PSTV)?
The stock price for Plus Therapeutics (NASDAQ: PSTV) is $6.53 last updated April 20, 2026 at 9:30 AM EDT.
Does Plus Therapeutics (PSTV) pay a dividend?
There are no upcoming dividends for Plus Therapeutics.
When is Plus Therapeutics (NASDAQ:PSTV) reporting earnings?
Plus Therapeutics does not have any upcoming earnings scheduled.
Is Plus Therapeutics (PSTV) going to split?
There is no upcoming split for Plus Therapeutics.
What sector and industry does Plus Therapeutics (PSTV) operate in?
Plus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
